AKT1 and neoplasm: Studies on the molecular mechanisms involved in tumor pathogenesis and progression have led to the identification of key tumor signal transduction pathways such as PI3K/Akt/NF-κB or Ras-Raf-MEK-ERK and p38 MAPK, which become a promising therapeutic option for several types of malignant diseases.